ストックスクリーナーアプリを入手
9.93
1.02%
0.10
前日終値:
$9.83
開ける：
$9.79
24時間の取引高:
63,658
Relative Volume:
0.61
時価総額：
$84.60M
収益：
$153.73M
当期純損益:
$-106.79M
株価収益率:
-5.5787
EPS:
-1.78
ネットキャッシュフロー:
$-115.93M
1週間 パフォーマンス:
+16.89%
1か月 パフォーマンス:
+9.75%
6か月 パフォーマンス:
+24.26%
1年 パフォーマンス:
-53.16%
1日の値動き範囲:
$9.525
$10.10
1週間の範囲:
$8.12
$10.10
52週間の値動き範囲:
$5.231
$21.90
Sutro Biopharma Inc Stock (STRO) Company Profile
名前
Sutro Biopharma Inc
セクター
電話
650-392-8412
住所
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
STRO
Sutro Biopharma Inc
|
9.93 | 83.75M | 153.73M | -106.79M | -115.93M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-16 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-03-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2025-03-14 | ダウングレード | BofA Securities | Buy → Underperform |
| 2025-03-14 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
| 2025-03-14 | ダウングレード | Wedbush | Outperform → Neutral |
| 2024-05-08 | 開始されました | BofA Securities | Buy |
| 2023-11-09 | 開始されました | Deutsche Bank | Buy |
| 2023-10-06 | 開始されました | Oppenheimer | Outperform |
| 2023-03-21 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-08-18 | 再開されました | Wells Fargo | Overweight |
| 2021-06-18 | 開始されました | H.C. Wainwright | Buy |
| 2020-12-03 | 開始されました | Stifel | Buy |
| 2020-09-02 | 開始されました | Jefferies | Buy |
| 2020-07-16 | 開始されました | Wells Fargo | Overweight |
| 2020-01-13 | 開始されました | SunTrust | Buy |
| 2019-10-07 | 開始されました | BTIG Research | Buy |
| 2019-07-18 | 開始されました | Deutsche Bank | Buy |
| 2019-04-29 | 開始されました | H.C. Wainwright | Buy |
| 2018-10-22 | 開始されました | JMP Securities | Mkt Outperform |
| 2018-10-22 | 開始されました | Piper Jaffray | Overweight |
| 2018-10-22 | 開始されました | Wedbush | Outperform |
すべてを表示
Sutro Biopharma Inc (STRO) 最新ニュース
Wells Fargo Reaffirms Their Hold Rating on Sutro Biopharma (STRO) - The Globe and Mail
RBF Capital LLC Purchases New Position in Sutro Biopharma, Inc. $STRO - MarketBeat
Velan Capital Investment Management LP Acquires 2,030,000 Shares of Sutro Biopharma, Inc. $STRO - MarketBeat
Exit Recap: Will Sutro Biopharma Inc stock benefit from automationTrade Analysis Report & Low Risk Growth Stock Ideas - moha.gov.vn
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Sutro Biopharma (NASDAQ:STRO) Shares Gap DownWhat's Next? - MarketBeat
Will Sutro Biopharma Inc. (S09) stock sustain bullish trend into 20252025 Big Picture & AI Forecasted Stock Moves - Newser
Can Sutro Biopharma Inc. stock sustain institutional interestJuly 2025 Institutional & Smart Investment Allocation Tips - Newser
Is Sutro Biopharma Inc. (S09) stock a top dividend aristocrat candidatePrice Action & Weekly Market Pulse Alerts - Newser
Sutro Biopharma (NASDAQ:STRO) Shares Gap UpWhat's Next? - MarketBeat
Is Sutro Biopharma Inc. (S09) stock attractive for growth fundsPortfolio Risk Report & Weekly Watchlist of Top Performers - Newser
Sutro Biopharma doses first patients in phase 1 trial of STRO-004 - Investing.com Canada
Sutro Biopharma (NASDAQ:STRO) Receives "Neutral" Rating from Wedbush - MarketBeat
Sutro Biopharma Announces Reverse Stock Split - TipRanks
Sutro Biopharma (NASDAQ:STRO) Given Neutral Rating at Wedbush - Defense World
Sutro Biopharma Initiates Dosing in Phase 1 TF-Expressing Cancer Study - MarketScreener
Sutro Biopharma (STRO) Initiates Phase 1 Trial of STRO-004 for S - GuruFocus
Sutro Biopharma announces first cohort of patients dosed in phase 1 trial of Stro-004 - marketscreener.com
Are Smart Investors Making the Right Decision? Sutro Biopharma Inc (STRO) - setenews.com
Sutro Biopharma doses first patients in phase 1 trial of STRO-004 By Investing.com - Investing.com South Africa
Sutro Biopharma, Inc. Announces First Cohort of Patients Dosed in Phase 1 Trial of STRO-004, a Next-Generation Tissue Factor ADC, in Tissue Factor - marketscreener.com
What MACD trends signal for Sutro Biopharma Inc. (S09) stockWeekly Market Outlook & Low Volatility Stock Recommendations - Newser
Will Sutro Biopharma Inc. stock outperform value stocks2025 Market Overview & AI Enhanced Execution Alerts - Newser
Sutro Biopharma falls as it announces 1-for-10 reverse stock split - MSN
Why Sutro Biopharma Inc. stock is popular among millennials2025 Breakouts & Breakdowns & Daily Profit Maximizing Trade Tips - Newser
How Sutro Biopharma Inc. stock reacts to inflationary pressures2025 Big Picture & High Return Trade Opportunity Guides - Newser
What earnings margins imply for Sutro Biopharma Inc. (S09) stockEarnings Trend Report & Daily Technical Stock Forecast Reports - Newser
Sutro Biopharma announces 1-for-10 reverse stock split By Investing.com - Investing.com Australia
Sutro Biopharma stock falls after announcing 1-for-10 reverse split - Investing.com Canada
Sutro Biopharma Sets 1-for-10 Reverse Stock Split - Nasdaq
Sutro Biopharma Announces 1-for-10 Reverse Stock Split - The Manila Times
Sutro Biopharma announces 1-for-10 reverse stock split - marketscreener.com
Can Sutro Biopharma Inc. stock continue upward trendMarket Risk Analysis & Reliable Price Breakout Alerts - BỘ NỘI VỤ
Holdings of Sutro Biopharma Inc (STRO) are aligned with the stars - Setenews
Is Sutro Biopharma Inc. stock a contrarian buyQuarterly Investment Review & Risk Managed Trade Strategies - moha.gov.vn
Can Sutro Biopharma Inc. stock reach $100 price target2025 Top Decliners & Daily Profit Focused Screening - newser.com
How reliable is Sutro Biopharma Inc. (S09) stock dividend growthMarket Sentiment Summary & AI Based Trade Execution Alerts - newser.com
Why Sutro Biopharma Inc. stock attracts global investorsSwing Trade & High Conviction Investment Ideas - newser.com
Statistical indicators supporting Sutro Biopharma Inc.’s strengthWeekly Investment Summary & Consistent Income Trade Ideas - newser.com
Can Sutro Biopharma Inc. recover in the next quarterPortfolio Return Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Applying big data sentiment scoring on Sutro Biopharma Inc.2025 Market WrapUp & Risk Controlled Daily Plans - newser.com
Can Sutro Biopharma Inc. (S09) stock sustain institutional flowsWeekly Profit Recap & Verified Technical Trade Signals - newser.com
Sutro Biopharma Inc (STRO) 財務データ
収益
当期純利益
現金流量
EPS
Sutro Biopharma Inc (STRO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Chow Gregory K. | CFO |
Oct 15 '25 |
Buy |
0.81 |
19,750 |
15,998 |
19,750 |
| Chung Jane | Chief Executive Officer |
Oct 15 '25 |
Buy |
0.80 |
12,500 |
10,011 |
122,850 |
| MATSUI CONNIE | Director |
Oct 15 '25 |
Buy |
0.80 |
50,000 |
39,950 |
50,000 |
| Pauling David | Chief Admin. Ofcr. & GC |
Oct 15 '25 |
Buy |
0.80 |
12,504 |
9,993 |
71,737 |
| Gerber Hans-Peter | CHIEF SCIENTIFIC OFFICER |
Sep 18 '25 |
Option Exercise |
0.00 |
37,500 |
0 |
68,249 |
| Leyman Barbara | Chief Business Officer |
Jul 08 '25 |
Option Exercise |
0.00 |
25,000 |
0 |
25,000 |
| Chung Jane | Chief Executive Officer |
Aug 09 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
117,058 |
| ALBINI EDWARD C | CFO AND SECRETARY |
May 15 '25 |
Option Exercise |
0.00 |
44,719 |
0 |
176,800 |
| FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
37,849 |
0 |
133,282 |
| Srinivasan Venkatesh | CHIEF TECH OP OFFICER |
May 01 '25 |
Option Exercise |
0.00 |
2,500 |
0 |
54,580 |
0.36%
1.05%
大文字化:
|
ボリューム (24 時間):